These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21807804)

  • 1. Nonpharmacologic interventions need outcomes for evaluating complex interventions in rheumatic diseases.
    Guillemin F; Iversen MD; Rat AC; Osborne R; Petersson IF
    J Rheumatol; 2011 Aug; 38(8):1803-5. PubMed ID: 21807804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials.
    Brooks P; Boers M; Simon LS; Strand V; Tugwell P; Idzerda L
    J Rheumatol; 2011 Jul; 38(7):1450-51. PubMed ID: 21724714
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMERACT: an international initiative to improve outcome measurement in rheumatology.
    Boers M; Brooks P; Simon LS; Strand V; Tugwell P
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S10-3. PubMed ID: 16273779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.
    Tunis SR; Maxwell LJ; Graham ID; Shea BJ; Beaton DE; Bingham CO; Brooks P; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2017 Oct; 44(10):1551-1559. PubMed ID: 28765256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of OMERACT to rheumatic disease research.
    Singh JA; Solomon DH; Dougados M; Felson D; Hawker G; Katz P; Paulus H; Siegel J; Wallace C
    Arthritis Rheum; 2007 Feb; 57(1):186. PubMed ID: 17266140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Using the International Classification of Functioning, Disability, and Health in rheumatologic rehabilitation].
    Weigl M; Schwarzkopf SR; Stucki G
    Z Rheumatol; 2008 Nov; 67(7):565-74. PubMed ID: 18825392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group.
    Singh JA; Dohm M; Choong PF
    BMC Musculoskelet Disord; 2017 Jan; 18(1):45. PubMed ID: 28125985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
    Kirwan JR; Tugwell PS
    J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.
    Kirwan JR; Minnock P; Adebajo A; Bresnihan B; Choy E; de Wit M; Hazes M; Richards P; Saag K; Suarez-Almazor M; Wells G; Hewlett S
    J Rheumatol; 2007 May; 34(5):1174-7. PubMed ID: 17477482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of OMERACT 10, the International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. May 4-8, 2010. Kota Kinabalu, Borneo.
    J Rheumatol; 2011 Jul; 38(7):1448-518. PubMed ID: 22263235
    [No Abstract]   [Full Text] [Related]  

  • 17. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process.
    Stucki G; Boonen A; Tugwell P; Cieza A; Boers M
    J Rheumatol; 2007 Mar; 34(3):600-6. PubMed ID: 17343306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).
    de Wit M; Kirwan JR; Tugwell P; Beaton D; Boers M; Brooks P; Collins S; Conaghan PG; D'Agostino MA; Hofstetter C; Hughes R; Leong A; Lyddiatt A; March L; May J; Montie P; Richards P; Simon LS; Singh JA; Strand V; Voshaar M; Bingham CO; Gossec L
    Patient; 2017 Apr; 10(2):141-152. PubMed ID: 27704486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating the OMERACT filter at OMERACT 11.
    Kirwan JR; Boers M; Tugwell P
    J Rheumatol; 2014 May; 41(5):975-7. PubMed ID: 24788466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.
    O'Neill J; Rader T; Guillemin F; Boonen A; Christensen R; Lyddiatt A; Pardo JP; Welch V; Singh JA; Tugwell P
    J Rheumatol; 2014 Jan; 41(1):150-2. PubMed ID: 24128775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.